Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Average Rating of “Hold” from Analysts

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) has received a consensus recommendation of “Hold” from the six analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company.

A number of equities analysts recently commented on CZMWY shares. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. The Goldman Sachs Group cut shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th.

Carl Zeiss Meditec Trading Down 0.4%

CZMWY opened at $31.83 on Friday. The stock has a 50-day moving average price of $40.95 and a 200-day moving average price of $47.50. Carl Zeiss Meditec has a 12-month low of $29.92 and a 12-month high of $76.28.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.